| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/HYPERTENSIONAHA.107.099416 |
| P698 | PubMed publication ID | 17893424 |
| P50 | author | Friedrich Luft | Q20753057 |
| P2093 | author name string | Markus G Mohaupt | |
| Jürg Schmidli | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 825-828 | |
| P577 | publication date | 2007-09-24 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Management of uncontrollable hypertension with a carotid sinus stimulation device. | |
| P478 | volume | 50 |
| Q36208762 | A sympathetic view of the sympathetic nervous system and human blood pressure regulation |
| Q39209751 | Acute and chronic electrical activation of baroreceptor afferents in awake and anesthetized subjects. |
| Q46541664 | An implantable optical blood pressure sensor based on pulse transit time. |
| Q37810910 | Blood pressure control in resistant hypertension: new therapeutic options. |
| Q38392598 | Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure. |
| Q39720303 | Carotid baroreceptor stimulation for the treatment of resistant hypertension |
| Q38543355 | Carotid baroreflex activation therapy for resistant hypertension |
| Q37738031 | Carotid baroreflex activation: past, present, and future |
| Q41788525 | Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is corre |
| Q95817434 | Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic activation is the dominant contributor to |
| Q85318256 | CrossTalk opposing view: Which technique for controlling resistant hypertension? Carotid sinus stimulation |
| Q37973295 | Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis |
| Q51573014 | Effect of selective vagal nerve stimulation on blood pressure, heart rate and respiratory rate in rats under metoprolol medication. |
| Q86025418 | Electrical carotid baroreceptor stimulation |
| Q38553738 | Electrical carotid sinus stimulation: chances and challenges in the management of treatment resistant arterial hypertension |
| Q43526001 | Evidence that blood pressure remains under the control of arterial baroreceptors in renal hypertensive rats |
| Q22306470 | Point: Chronic Activation of the Sympathetic Nervous System is the Dominant Contributor to Systemic Hypertension |
| Q37815451 | Premise, promise, and potential limitations of invasive devices to treat hypertension |
| Q38085255 | Research needs in the area of device-related treatments for hypertension |
| Q34092857 | Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex |
| Q33936152 | Sympathetic nervous system and blood pressure in humans: individualized patterns of regulation and their implications |
| Q43235357 | The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management |
| Q28264609 | The human sympathetic nervous system: its relevance in hypertension and heart failure |
| Q38195525 | The role of nonpharmacologic device interventions in the management of drug-resistant hypertension |
| Q38194474 | The role of the kidney and the sympathetic nervous system in hypertension |
| Q30400547 | What we talk about when we talk with medical students |
| Q82061607 | [Blood pressure control after bilateral carotid angioplasty in a patient with severe hypertension--case report] |
Search more.